EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Quinazoline derivatives with dual EGFR and VEGFR-2 inhibition: insights from docking, molecular dynamics, and in vivo studies

Asmaa S A Yassen iD, Mohamed S Nafie iD, Safaa M Kishk iD, Claire Simons iD, Ranza Elrayess iD

RSC Advances · 2026

DOI: 10.1039/d6ra05621k ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Asmaa S A Yassen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University Ismailia 41522 Egypt asmaa_yaseeen@pharm.suez.edu.eg. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Llywodraeth Cymru.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel Quinazoline derivative exhibited potent anticancer activity and dual EGFR and VEGFR-2 inhibition: in vitro , in silico , and in vivo studies.

Autor:innen und Institutionen

  • Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University Ismailia 41522 Egypt asmaa_yaseeen@pharm.suez.edu.eg.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Galala University New Galala 43713 Egypt asmaa.yassen@gu.edu.eg.
  • Department of Chemistry, College of Sciences, University of Sharjah P.O. 27272 Sharjah United Arab Emirates mohamed.ElSayed@sharjah.ac.ae.
  • Department of Chemistry, Faculty of Science, Suez Canal University Ismailia 41522 Egypt mohamed_nafie@science.suez.edu.eg.
  • Pharmaceutical Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University Ismailia 41522 Egypt.
  • School of Pharmacy & Pharmaceutical Sciences, Cardiff University King Edward VII Avenue Cardiff CF10 3NB UK.

ORCID-Profile: Asmaa S A Yassen, Mohamed S Nafie, Safaa M Kishk, Claire Simons, Ranza Elrayess

Förderung

  • Llywodraeth Cymru

Zitieren

APA

Yassen, A. S. A., Nafie, M. S., Kishk, S. M., Simons, C., & Elrayess, R. (2026). Quinazoline derivatives with dual EGFR and VEGFR-2 inhibition: insights from docking, molecular dynamics, and in vivo studies. RSC Advances. https://doi.org/10.1039/d6ra05621k

Vancouver

Yassen ASA, Nafie MS, Kishk SM, Simons C, Elrayess R. Quinazoline derivatives with dual EGFR and VEGFR-2 inhibition: insights from docking, molecular dynamics, and in vivo studies. RSC Advances. 2026. doi:10.1039/d6ra05621k

BibTeX
@article{Yassen2026,
  author = {Yassen, Asmaa S A and Nafie, Mohamed S and Kishk, Safaa M and Simons, Claire and Elrayess, Ranza},
  title = {Quinazoline derivatives with dual EGFR and VEGFR-2 inhibition: insights from docking, molecular dynamics, and in vivo studies},
  journal = {RSC Advances},
  year = {2026},
  doi = {10.1039/d6ra05621k}
}
Kostenlos starten →